ONCY
ONCY
NASDAQ · Biotechnology

Oncolytics Biotech Inc

$0.89
+0.05 (+5.89%)
As of Feb 8, 2:09 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 14.90M 15.53M 15.53M
Net Income 2.54M 3.35M 2.88M
EPS
Profit Margin 17.0% 21.6% 18.5%
Rev Growth -8.5% -1.6% +3.5%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 14.94M 12.63M 13.72M
Total Equity 86.70M 73.73M 86.18M
D/E Ratio 0.17 0.17 0.16
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 5.18M 5.39M 5.26M
Free Cash Flow 2.62M 3.23M 2.70M